PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	41.69	56.56	73.82	65.24	28.84
Cash & Short-Term Investments	39.98	41.69	56.56	73.82	65.24	28.84
Cash Growth	-30.75%	-26.29%	-23.38%	13.15%	126.23%	137.13%
Prepaid Expenses	-	3.36	2.49	2.66	1.6	1.5
Total Current Assets	-	45.05	59.06	76.48	66.84	30.34
Property, Plant & Equipment	-	0.3	0.34	0.53	0.36	0.55
Total Assets	-	45.36	59.39	77.01	67.2	30.89
Accounts Payable	-	1.68	6.98	1.22	1.31	1.42
Accrued Expenses	-	2.84	2.42	8.31	2.19	1.74
Short-Term Debt	-	12.5	4.17	-	-	-
Current Portion of Leases	-	0.06	0.06	0.29	0.26	0.12
Total Current Liabilities	-	17.09	13.63	9.82	3.76	3.27
Long-Term Debt	-	9.2	19.51	23.02	-	-
Long-Term Leases	-	0.06	0.12	0.16	0.23	0.49
Total Liabilities	-	26.35	33.26	33.01	3.99	3.76
Common Stock	-	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	-	201.1	170.62	145.55	123.9	70.91
Retained Earnings	-	-182.11	-144.5	-101.56	-60.7	-43.79
Shareholders' Equity	22.36	19	26.13	44	63.21	27.13
Total Liabilities & Equity	-	45.36	59.39	77.01	67.2	30.89
Total Debt	18.96	21.83	23.85	23.47	0.49	0.61
Net Cash (Debt)	21.02	19.86	32.71	50.35	64.75	28.23
Net Cash Growth	-36.99%	-39.28%	-35.03%	-22.25%	129.38%	132.12%
Net Cash Per Share	0.52	0.54	1.06	1.76	2.53	1.69
Filing Date Shares Outstanding	45.9	45.4	36.68	30.72	28.45	22.26
Total Common Shares Outstanding	45.9	37.99	33.09	30.17	28.45	22.26
Working Capital	-	27.97	45.43	66.66	63.08	27.07
Book Value Per Share	0.49	0.50	0.79	1.46	2.22	1.22
Tangible Book Value	22.36	19	26.13	44	63.21	27.13
Tangible Book Value Per Share	0.49	0.50	0.79	1.46	2.22	1.22
Machinery	-	0.3	0.27	0.12	0.12	0.12

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q